LumaCina Appoints Gary Bird as CEO to Accelerate Growth and Expand Global Sterile Injectables Portfolio

Executive Chair Mark Crotty to continue guiding long-term strategic direction PERTH, Australia,…

GEM and Senhwa Biosciences have formally executed a Share Purchase Agreement for up to NT$500 million

TAIPEI and SAN DIEGO, July 15, 2026 /PRNewswire/ — GEM Global Yield…

Radisson Hotel Group highlights strategic growth across Southeast Asia Pacific

BANGKOK and BRUSSELS, July 15, 2026 /PRNewswire/ — Across the region, Radisson Hotel…

De Tomaso Advances Next-Generation V12 Programme with Italtecnica

HONG KONG and TURIN, Italy, July 15, 2026 /PRNewswire/ — OIO Group…

CGS International Retains ASEAN's Leading Broker Position in the 2026 Extel Asia Local Broker Survey

Ranked the #1 overall broker in Malaysia, and among the top three…

Newmark Expands Hong Kong Capabilities, Appointing Nick Hinton As Head Of Project Management

HONG KONG, July 15, 2026 /PRNewswire/ — Newmark Group, Inc. (Nasdaq: NMRK)…

LONGi Makes S&P Global Energy Premier List of Tier 1 Cleantech Companies 2026

XI’AN, China, July 15, 2026 /PRNewswire/ — LONGi Green Energy Technology Co.,…

Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint

As a head-to-head Phase III trial comparing sac-TMT plus pembrolizumab with the…